Bessemer Venture Partners

Inductive Bio develops a machine learning platform that accelerates compound optimization for pharmaceutical research. It focuses on building datasets and ML models to predict absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of small molecules, enabling scientists to optimize initial compounds into leads and development candidates more efficiently.

Folx Health is a Boston-based telehealth platform founded in 2020, specializing in digital healthcare services tailored for the LGBTQIA+ community. It offers access to queer and trans clinicians, focusing on gender-affirming hormone therapy, sexual health, and family creation services.

Medisage is a global community of Doctors Connect with Global doctors, watch video case studies by subject matter experts, read latest medical news and discuss patient cases.

House Rx is a health technology platform focused on improving affordability and patient access to specialty medications.

Rupa Health operates an online platform that facilitates access to alternative healthcare providers and streamlines the process of ordering lab tests. Founded in 2018 and based in San Francisco, the company offers a comprehensive service that enables doctors to order specialty lab work, manage samples, and receive results efficiently. The platform integrates seamlessly with various lab companies, allowing healthcare professionals to order multiple tests in one place without requiring membership or subscription fees. Rupa Health also provides flexible payment options and robust support for both practitioners and patients, ensuring an efficient lab experience. The company's services include shipping test reports directly to patients' homes, simplifying the management and tracking of lab results to enhance patient care.

NephroPlus operates a network of dialysis centers dedicated to delivering quality renal care at affordable prices through standardized protocols, continuous staff training, and focused process innovation. The network provides dialysis services and related treatments such as kidney stone management and arteriovenous fistula procedures, along with other renal and urological care, enabling patients to access specialized treatment and improve recovery.

Nym Health Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in medical coding technology for healthcare facilities. Its core product, Nym, is an autonomous coding solution that streamlines revenue cycle management. Nym reduces denials and operational expenses by directly billing and accurately assigning medical charge codes from patient charts, improving payment cycles and audit-readiness. It identifies relevant clinical aspects, assigns codes, and provides an audit trail explaining its coding decisions. With a research and development center in Tel Aviv-Yafo, Israel, Nym enables healthcare providers to enhance coding quality, lower costs, and focus more on patient care.

Clearing is a digital healthcare platform built to serve the more than 50M chronic pain sufferers in the United States. In partnership with leading physicians and researchers at Harvard, Johns Hopkins, and the Hospital for Special Surgery, and with significant funding from top-tier investors Bessemer Venture Partners, Founders Fund, Breyer Capital, and a host of leading healthcare and consumer entrepreneurs (including the founders of Hims, Seamless Grubhub, Flatiron Health, Forward Health, Curology and more) we are on a mission to provide patients with access to comprehensive, opioid-free pain relief.

Folx Health is a Boston-based telehealth platform founded in 2020, specializing in digital healthcare services tailored for the LGBTQIA+ community. It offers access to queer and trans clinicians, focusing on gender-affirming hormone therapy, sexual health, and family creation services.

Folx Health is a Boston-based telehealth platform founded in 2020, specializing in digital healthcare services tailored for the LGBTQIA+ community. It offers access to queer and trans clinicians, focusing on gender-affirming hormone therapy, sexual health, and family creation services.

Nym Health Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in medical coding technology for healthcare facilities. Its core product, Nym, is an autonomous coding solution that streamlines revenue cycle management. Nym reduces denials and operational expenses by directly billing and accurately assigning medical charge codes from patient charts, improving payment cycles and audit-readiness. It identifies relevant clinical aspects, assigns codes, and provides an audit trail explaining its coding decisions. With a research and development center in Tel Aviv-Yafo, Israel, Nym enables healthcare providers to enhance coding quality, lower costs, and focus more on patient care.

Founded in 2018, Stuff That Works develops an AI-based online platform that crowdsources data on chronic disease treatments. It offers a web-based questionnaire for quantitative analysis, publishing insights on conditions like clinical depression, diabetes, and fibromyalgia. The platform enables users to discuss insights and contributes to ongoing research.

Folx Health is a Boston-based telehealth platform founded in 2020, specializing in digital healthcare services tailored for the LGBTQIA+ community. It offers access to queer and trans clinicians, focusing on gender-affirming hormone therapy, sexual health, and family creation services.

NephroPlus operates a network of dialysis centers dedicated to delivering quality renal care at affordable prices through standardized protocols, continuous staff training, and focused process innovation. The network provides dialysis services and related treatments such as kidney stone management and arteriovenous fistula procedures, along with other renal and urological care, enabling patients to access specialized treatment and improve recovery.

Founded in 2018, Stuff That Works develops an AI-based online platform that crowdsources data on chronic disease treatments. It offers a web-based questionnaire for quantitative analysis, publishing insights on conditions like clinical depression, diabetes, and fibromyalgia. The platform enables users to discuss insights and contributes to ongoing research.

Nym Health Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in medical coding technology for healthcare facilities. Its core product, Nym, is an autonomous coding solution that streamlines revenue cycle management. Nym reduces denials and operational expenses by directly billing and accurately assigning medical charge codes from patient charts, improving payment cycles and audit-readiness. It identifies relevant clinical aspects, assigns codes, and provides an audit trail explaining its coding decisions. With a research and development center in Tel Aviv-Yafo, Israel, Nym enables healthcare providers to enhance coding quality, lower costs, and focus more on patient care.

Candid Care Co. provides at-home orthodontic solutions through the delivery of customized clear aligners. Founded in 2017 and based in New York, with an additional office in Columbus, Ohio, the company simplifies the teeth straightening process by sending clients an impression kit to create models of their smiles. These models are then reviewed by licensed orthodontists who develop a personalized treatment plan and design a set of aligners tailored to the client's needs. Candid's approach allows customers to achieve their desired smile in an average of five months, all without needing to visit a dental office. The aligners are made from Bisphenol A-free plastic, which minimizes irritation compared to traditional braces, making the experience more comfortable for users.

Subtle Medical is a healthcare technology company that develops artificial‑intelligence software for magnetic resonance and positron emission tomography imaging. Its flagship products, SubtleMR and SubtlePET, are FDA‑cleared and CE‑marked tools that enhance image quality by reducing noise and sharpening detail, allowing scans to be performed faster and with lower radiation or contrast dose. The company’s deep‑learning algorithms integrate with any scanner without changing existing workflows, enabling imaging centers and hospitals to increase throughput and improve patient safety. Subtle Medical also offers a vendor‑agnostic AI platform that delivers analytics and support to clinical imaging providers. Founded in 2017 and headquartered in Menlo Park, California, the firm has received an NIH SBIR grant and an RSNA award for its GAD technology.

Candid Care Co. provides at-home orthodontic solutions through the delivery of customized clear aligners. Founded in 2017 and based in New York, with an additional office in Columbus, Ohio, the company simplifies the teeth straightening process by sending clients an impression kit to create models of their smiles. These models are then reviewed by licensed orthodontists who develop a personalized treatment plan and design a set of aligners tailored to the client's needs. Candid's approach allows customers to achieve their desired smile in an average of five months, all without needing to visit a dental office. The aligners are made from Bisphenol A-free plastic, which minimizes irritation compared to traditional braces, making the experience more comfortable for users.

Allena Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company based in Newton, Massachusetts, focused on the development and commercialization of innovative oral enzyme therapeutics for rare and severe metabolic and kidney disorders. Founded in 2011, the company’s lead product candidate, reloxaliase, is currently undergoing a pivotal Phase 3 clinical program aimed at treating enteric hyperoxaluria, a condition characterized by elevated urinary oxalate levels that can lead to kidney stones and chronic kidney disease. Additionally, Allena is developing ALLN-346, a novel enzyme intended to address hyperuricemia in patients with moderate to severe chronic kidney diseases. By targeting metabolic disorders associated with the accumulation of harmful metabolites, Allena Pharmaceuticals aims to provide effective treatments for patients facing serious health challenges.

Docent Health is a company based in Cambridge, Massachusetts, that specializes in developing software and mobile applications aimed at enhancing patient care and engagement for health systems. Its enterprise consumer engagement platform integrates digital and human interactions to provide personalized support for patients, guiding them according to their specific needs and preferences. By utilizing intelligent, real-time text messaging, Docent Health focuses on fostering lasting patient relationships and improving customer experiences. The company's approach combines insights from various industries, including retail and hospitality, to deliver customer-centric care that enhances patient satisfaction, increases customer lifetime value, and helps health systems grow their market share.

Docent Health is a company based in Cambridge, Massachusetts, that specializes in developing software and mobile applications aimed at enhancing patient care and engagement for health systems. Its enterprise consumer engagement platform integrates digital and human interactions to provide personalized support for patients, guiding them according to their specific needs and preferences. By utilizing intelligent, real-time text messaging, Docent Health focuses on fostering lasting patient relationships and improving customer experiences. The company's approach combines insights from various industries, including retail and hospitality, to deliver customer-centric care that enhances patient satisfaction, increases customer lifetime value, and helps health systems grow their market share.

Founded in 2011, Rock Health is a venture capital firm based in San Francisco. It specializes in investing in and supporting startups working at the intersection of healthcare and technology, with a focus on digital health.

Allena Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company based in Newton, Massachusetts, focused on the development and commercialization of innovative oral enzyme therapeutics for rare and severe metabolic and kidney disorders. Founded in 2011, the company’s lead product candidate, reloxaliase, is currently undergoing a pivotal Phase 3 clinical program aimed at treating enteric hyperoxaluria, a condition characterized by elevated urinary oxalate levels that can lead to kidney stones and chronic kidney disease. Additionally, Allena is developing ALLN-346, a novel enzyme intended to address hyperuricemia in patients with moderate to severe chronic kidney diseases. By targeting metabolic disorders associated with the accumulation of harmful metabolites, Allena Pharmaceuticals aims to provide effective treatments for patients facing serious health challenges.

Kurbo Health, Inc. is a company based in Palo Alto, California, that specializes in developing a mobile application aimed at assisting overweight children and their families in managing weight effectively. Founded in 2013, Kurbo employs mobile technology and personalized coaching to help users track their food intake and adopt healthier lifestyles. The platform incorporates games, challenges, and virtual feedback, leveraging research from pediatric obesity experts to provide a scalable solution for weight management. By utilizing engaging mobile apps and web-based tools, Kurbo facilitates behavior modification and promotes healthier eating habits among adolescents, making it easier for them to control their weight.

NephroPlus operates a network of dialysis centers dedicated to delivering quality renal care at affordable prices through standardized protocols, continuous staff training, and focused process innovation. The network provides dialysis services and related treatments such as kidney stone management and arteriovenous fistula procedures, along with other renal and urological care, enabling patients to access specialized treatment and improve recovery.

Lumere, Inc. is a Chicago-based company that offers a cloud-based platform designed to assist hospitals and physicians in reducing clinical variation and unnecessary costs associated with medical devices and pharmaceuticals. The platform features tools such as Product Introduction Management, which redefines the device vetting process through analysis of clinical evidence and best practices; Category Optimization, which integrates clinical insights with data from health systems to identify potential cost savings; and Variation Management, which analyzes procedural utilization data to evaluate how medical devices are used. Additionally, Utilization Management combines clinical information with prescriber patterns to optimize drug spending and address inappropriate usage. Lumere also provides physician advisory services to ensure alignment between healthcare providers and hospital management. Founded in 2012, Lumere was previously known as Procured, Inc., and operates as a subsidiary of Global Healthcare Exchange, LLC.

Allena Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company based in Newton, Massachusetts, focused on the development and commercialization of innovative oral enzyme therapeutics for rare and severe metabolic and kidney disorders. Founded in 2011, the company’s lead product candidate, reloxaliase, is currently undergoing a pivotal Phase 3 clinical program aimed at treating enteric hyperoxaluria, a condition characterized by elevated urinary oxalate levels that can lead to kidney stones and chronic kidney disease. Additionally, Allena is developing ALLN-346, a novel enzyme intended to address hyperuricemia in patients with moderate to severe chronic kidney diseases. By targeting metabolic disorders associated with the accumulation of harmful metabolites, Allena Pharmaceuticals aims to provide effective treatments for patients facing serious health challenges.

NephroPlus operates a network of dialysis centers dedicated to delivering quality renal care at affordable prices through standardized protocols, continuous staff training, and focused process innovation. The network provides dialysis services and related treatments such as kidney stone management and arteriovenous fistula procedures, along with other renal and urological care, enabling patients to access specialized treatment and improve recovery.

On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. There platform will enable better decision-making across multiple cancers: improving the quality of life for patients and ultimately increasing survival. Products currently in development are based on two core technologies: 1) DNA repair biomarkers that predict treatment response and 2) Microfluidic chip technology that enables capture, enumeration and characterization of circulating tumor cells (CTCs) in the bloodstream.

Vetic is a network of advanced pet clinics focused on delivering comprehensive health care services for animals. The company operates facilities equipped with modern medical infrastructure, including diagnostics and X-ray capabilities, allowing pet owners to manage their pets' health effectively. Vetic emphasizes personalized treatment and nutrition, enabling pet parents to provide optimal care without the hassle of long wait times associated with prior appointments. Through its innovative approach, Vetic aims to enhance the overall experience of veterinary care for both pets and their owners.